Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on May 11, 2005
J Am Soc Nephrol 16: 2141-2149, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004090776

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004090776v1
16/7/2141    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenkins, D.
Right arrow Articles by Woolf, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenkins, D.
Right arrow Articles by Woolf, A. S.

Human Genetics

De Novo Uroplakin IIIa Heterozygous Mutations Cause Human Renal Adysplasia Leading to Severe Kidney Failure

Dagan Jenkins*,{dagger}, Maria Bitner-Glindzicz{dagger}, Sue Malcolm{dagger}, Chih-Chi A. Hu{ddagger}, Jennifer Allison*, Paul J.D. Winyard*, Ambrose M. Gullett*, David F.M. Thomas§, Rachel A. Belk§, Sally A. Feather§, Tung-Tien Sun{ddagger} and Adrian S. Woolf*

* Nephro-Urology; {dagger} Clinical & Molecular Genetics Units, Institute of Child Health, University College London, London, United Kingdom; {ddagger} Ronald O. Perelman Department of Dermatology and Departments of Pharmacology and Urology, New York University School of Medicine, New York, New York; and § Departments of Paediatric Urology and Nephrology, St. James’ University Hospital, Leeds, United Kingdom

Address correspondence to: Dagan Jenkins, Nephro-Urology Unit, Institute of Child Health, University College London, 30 Guilford Street, London WC1E 1EH, UK. Phone: +44-0-20-7905-2663; Fax: +44-0-20-7905-2133; E-mail: d.jenkins{at}ich.ucl.ac.uk

Received for publication September 17, 2004. Accepted for publication March 22, 2005.

Human renal adysplasia usually occurs sporadically, and bilateral disease is the most common cause of childhood end-stage renal failure, a condition that is lethal without intervention using dialysis or transplantation. De novo heterozygous mutations in Uroplakin IIIa (UPIIIa) are reported in four of 17 children with kidney failure caused by renal adysplasia in the absence of an overt urinary tract obstruction. One girl and one boy in unrelated kindreds had a missense mutation at a CpG dinucleotide in the cytoplasmic domain of UPIIIa (Pro273Leu), both of whom had severe vesicoureteric reflux, and the girl had persistent cloaca; two other patients had de novo mutations in the 3' UTR (963 T->G; 1003 T->C), and they had renal adysplasia in the absence of any other anomaly. The mutations were absent in all sets of parents and in siblings, none of whom had radiologic evidence of renal adysplasia, and mutations were absent in two panels of 192 ethnically matched control chromosomes. UPIIIa was expressed in nascent urothelia in ureter and renal pelvis of human embryos, and it is suggested that perturbed urothelial differentiation may generate human kidney malformations, perhaps by altering differentiation of adjacent smooth muscle cells such that the metanephros is exposed to a functional obstruction of urine flow. With advances in renal replacement therapy, children with renal failure, who would otherwise have died, are surviving to adulthood. Therefore, although the mechanisms of action of the UPIIIa mutations have yet to be determined, these findings have important implications regarding genetic counseling of affected individuals who reach reproductive age.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
G. Williams, J. T. Fletcher, S. I. Alexander, and J. C. Craig
Vesicoureteral Reflux
J. Am. Soc. Nephrol., May 1, 2008; 19(5): 847 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H Kelly, C M Molony, J M Darlow, M E Pirker, A Yoneda, A J Green, P Puri, and D E Barton
A genome-wide scan for genes involved in primary vesicoureteric reflux
J. Med. Genet., November 1, 2007; 44(11): 710 - 717.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. Kerecuk, A. Sajoo, L. McGregor, J. Berg, M. R. Haq, N. J. Sebire, C. Bingham, E. L. Edghill, S. Ellard, J. Taylor, et al.
Autosomal dominant inheritance of non-syndromic renal hypoplasia and dysplasia: dramatic variation in clinical severity in a single kindred
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 259 - 263.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Jenkins, M. Bitner-Glindzicz, S. Malcolm, J. Allison, R. de Bruyn, S. Flanagan, D. F. M. Thomas, R. A. Belk, S. A. Feather, C. Bingham, et al.
Mutation analyses of Uroplakin II in children with renal tract malformations
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3415 - 3421.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. S. Woolf
Renal Hypoplasia and Dysplasia: Starting to Put the Puzzle Together
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2647 - 2649.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T.-T. Sun
Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F9 - F21.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP